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Abstract
Objective. In this studywe developed an automaticmethod to predict tumour volume and shape in
weeks 3 and 4 of radiotherapy (RT), using cone-beam computed tomography (CBCT) scans acquired
up toweek 2, allowing identification of large tumour changes.Approach. 240 non-small cell lung
cancer (NSCLC) patients, treatedwith 55Gy in 20 fractions, were collected. CBCTswere rigidly
registered to the planning CT. Intensity values were extracted in each voxel of the planning target
volume across all CBCT images fromdays 1, 2, 3, 7 and 14. For each patient and in each voxel, four
regressionmodels werefitted to voxel intensity; applying linear, Gaussian, quadratic and cubic
methods. Thesemodels predicted the intensity value for each voxel inweeks 3 and 4, and the tumour
volume found by thresholding. Eachmodel was evaluated by computing the rootmean square error in
pixel value and structural similarity indexmetric (SSIM) for all patients. Finally, the sensitivity and
specificity to predict a 30%change in volumewere calculated for eachmodel.Main results. The linear,
Gaussian, quadratic and cubicmodels achieved a comparable similarity score, the average SSIM for all
patients was 0.94, 0.94, 0.90, 0.83 inweek 3, respectively. At week 3, a sensitivity of 84%, 53%, 90%
and 88%, and specificity of 99%, 100%, 91%and 42%were observed for the linear, Gaussian,
quadratic and cubicmodels respectively. Overall, the linearmodel performed best at predicting those
patients that will benefit fromRT adaptation. The linearmodel identified 21%and 23%of patients in
our cohort withmore than 30% tumour volume reduction to benefit from treatment adaptation in
weeks 3 and 4 respectively. Significance.We have shown that it is feasible to predict the shape and
volume ofNSCLC tumours from routine CBCTs and effectively identify patients whowill respond to
treatment early.
1. Introduction
Non-small cell lung cancer (NSCLC)patients are a diverse population, with different characteristics, tumour
sizes and tumour biology. For, inoperableNSCLCpatients, radiotherapy (RT), chemotherapy or the
combination are treatment options (Fried et al 2014, Postmus et al 2017). During RTof lung cancer, varying
degree of tumour-response has been observed (Das et al 2010, Barker et al 2015, O’Connor et al 2015). Some
tumours shrink during RTwhile others showno change in tumour size. Given this heterogeneity in tumour
response, there is a clinical need to identify patients who are responding to RT as early in their treatment as
possible.
Medical imaging is increasingly used as a non-invasive way to assess tumour response to treatment. Unlike,
invasive techniques such as biopsies, imaging can provide spatial and temporal information about the tumour
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RT related toxicities. In recent years, novel treatment techniques such as adaptive radiotherapy (ART) have
emerged in the treatment planning process (Guckenberger et al 2012). ARTwhichwasfirst described byYan et al
(1997), and aims to optimise RTby incorporating patient-level changes observed during RT in treatment plan
modification.However,most previous studies have used computed tomography (CT) or positron emission
tomographywithCT to evaluate tumour regression for ART (Guckenberger et al 2011, Berkovic et al 2017,
Roengvoraphoj et al 2018).
In lung RT, cone-beam computed tomography (CBCT) images arewidely used to verify the patient’ position
before treatment. CBCT images can provide additional information about the tumour on the day of treatment.
Previous studies have utilisedCBCT images tomonitor tumour response and demonstratedARTduring the
course of RT of lung cancer patients (Elsayad et al 2016,Møller et al 2016). Elsayad et al (2016) reported
intrathoracic changes in 74%of patients occurringwithin the first threeweeks of treatment. Adaptations were
performed in 60% (N=43) of the patients. However, in 25%of patients, new planningCT (pCT) for
adaptation needed to be performedwith urgency. In a larger study (N=177) applying a strict adaptation
criterion,Møller et al (2016) found that adaptation decreased lung dose in 75%of all the patients with ART. In
both studies, adaptationwas triggered by visually observed changes. Triggered adaptation is unpredictable and
can constraint arrangements for resource allocation (re-scanning and re-planning). Contrarily, identifying
patients whowill benefit fromART early on during the course of RTwill enable departments to plan, schedule
and predict the resources that will need to be allocated.
This study posits that automatic analysis of CBCT images taken early in treatment (weeks 1 and 2) can be




In this retrospective study, 240NSCLCpatients who received 55Gy in 20 fractions, with orwithout induction
chemotherapy, treated at TheChristieNHSTrust between 1 January 2013 and 31October 2018were collected.
All images were collectedwith theChristieNHSTrust approval (UKCat, REC reference 17/NW/0060). Patient
demographics are summarised in table 1 of supplementarymaterial (available online at stacks.iop.org/PMB/
66/225002/mmedia). All patients includedmet the following requirements; (1)CBCT images were available of
thefirst three fractions, as well as CBCT images at fraction seven and fourteen, and (2)CBCT images were
available inweeks 3 and 4. (3)CBCTs have sufficient image quality and no signs of non-tumour pulmonary
changes such as atelectasis. A radiation oncologist reviewed all CBCTs identified to have insufficient quality and
non-tumour pulmonary changes. These criteria resulted in a study cohort of 201 patients with a total of 1206
CBCT images. No other patient selection criteria were used.
2.2. Image registration
The purpose of image registration is tofind the appropriate transformation (T) that spatiallymaps
corresponding pixels between pCT and subsequent CBCTs. Image registrationwas performed to automatically
rigidly align follow upCBCT images to the pCT, using a two-step alignment process. Thefirst step involved the
rigid alignment of bony anatomy in 3D, correcting for patient rotations and translations along all three axes.
This was achieved by creating a region of interest (ROI) including the vertebrae in all CT slices containing
planning target volume (PTV). Next, registrationwas fine-tuned to align the soft tissue, using translations only.
For this, a ROI containing the PTVwas created, ensuring that the alignment of the soft tissue includes the gross
tumour volume (GTV) and surrounding lung.
All registrationswere visually checked for large errors. Image registrationwas performed using in-house
software,World-match v9.0 (Wolthaus et al 2005), using the identical algorithm as used inXVI v5.6.No user
interactionwas involved at all.
2.3.Definition of region interest for pixel value analysis
All registered CBCT images were normalised to correct intensity information: tofix calibration differences
between treatmentmachines and to allow comparison of CBCTbetween patients using the approach adapted
fromvanTimmeren et al (2017), as described in our earlier work (Amugongo et al 2020). After, all CBCTswere
cropped to focus on the tumour. A rectangular ROIwas created using theGTV contour as defined on pCT,
expanded by 1.3 cm, see figure 1(a)). This expansion is compatible with the extent ofmicroscopic disease spread
that rarely falls outside 1.3 cm from the radiographically definedGTV (Giraud et al 2000). In addition, an
extension of 1.3 cmwas used to include the immediately surrounding tissue in the prediction to allow enough
surrounding tissue to be visible.
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This part of theworkwas also carried out usingWorld-match v9.0 (in-house software).
2.4. Prediction of density changes in each voxel
For all patients, intensity values were extracted in each voxel across all CBCT images fromdays 1, 2, 3, 7 and 14
(see figure 1(b)); these days correspond to the offline standard imaging protocol used in our institution at the
time. In each voxel, four regressionmodels were fitted, applying linear, quadratic and cubic polynomials, and a
Gaussian processmethod. TheGaussian process is a generic supervised learning technique developed to solve
regression and probabilistic classification problems (Rasmussen andWilliams 2006). Thesemodels were used
for extrapolation in the time domain and predict intensity values in each voxel for theCBCT image inweek 3
(days 17–21) and 4 (days 24–28) of RT respectively, see figure 1(c)). The predicted intensity values for all voxels
were visualised in 3D.
This part of theworkwas performed in python version 3.7, using polyfit regression, included in theNumPy
package.
2.5. Tumour segmentation
Image segmentation by thresholding is a simple but powerful technique for segmenting images having bright
intensities on dark background. In this study, a thresholding approachwas used to segment the tumour volume.
To get an approximateGTV segmentation in the predicted and the actual CBCT image acquired inweeks 3 and 4
of RT. Three threshold values were tested, and the threshold value of 374HUprovided the best segmentation
results was chosen and applied. All pixel intensities above 374HUwere classified as tumour and included in the
tumour segmentation. To guide the thresholding process, theGTV contour defined on the pCT expanded by 5
mmwas used (seefigure 1(d)), with thresholding performed inside this region only. This approachwas preferred
for its simplicity. The segmented tumour volumeswere visually verified to exclude gross errors and exported as
Neuroimaging Informatics Technology Initiative files. Sensitivity analysis was performed to see how changing
the threshold value affects the segmented tumour volume. For this, segmentation threshold values of 281 and
468HUwere applied.
This part of theworkwas carried out in python version 3.7 usingNumPy andNiBabel packages.
Figure 1. Schematic diagramof our approach. (a)After rigid image registration, ROIwas defined, andCBCT imageswere cropped to
focus on the tumour. (b)CBCTs fromdays 1, 2, 3, 7 and 14were stacked up into a 4D array and intensity extracted in each voxel across.
(c)Apolynomialmodel was used to predict the value in a given voxel in weeks 3 and 4 of RT. (d) predicted volume inweek 3 or 4.
(e)The predicted tumourwas automatically isolated by applying a threshold and volume calculated.
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2.6.Model evaluation
For eachmodel, the rootmean square error (RMSE)was calculated in each voxel and summarised for each
patient. RMSEmeasures the averagemagnitude of the errors between the predicted and actualmeasured values.
Unlike othermetrics, such asmean square error andmean absolute error, RMSEdoes not take the absolute value
and gives highweight to large errors (Hyndman andKoehler 2006).
An independentmetric, the structural similarity indexmetric (SSIM), was also used to assess visual
similarities between the predicted and actual CBCT images acquired inweeks 3 and 4 of RT.Unlike RMSEwhich
tries to estimate the perceived errors between the predicted and actual voxel intensities, SSIM is a perceptual
metric that quantifies the similarities between two images by looking at the change in structural information; i.e.
if voxel intensities in the two images have similar density values or line-up (Wang et al 2004). The range of SSIM
is from−1 to 1, and SSIMof 1 indicates that the two images (predicted and actual) to be identical and−1means
no similarity. SSIMwas implemented as described byWang et al (2004). Briefly, SSIM is used to compare the
predicted and actual CBCT images. Therefore, quantify the visibility of errors (differences) between the
predicted and actual CBCT images. SSIM andRMSEwere calculated permodel for all patients, comparing the
observed actual CBCT images acquired inweeks 3 and 4 of RT,with the corresponding images generated by the
models. The rangewas computed for eachmodel.
For each patient, the tumourwas segmented from the predicted and actual CBCT image acquired inweek 3
and 4 of RT and tumour volume in cm3were computed.Next, themean distance to agreement (DTA) in
millimetres (mm) between the segmented tumour volume frompredicted and actual CBCT images was
calculated. In this study, we defineDTA as theminimumdistance from each point on the surface of the
segmented predicted volume to the actual tumour volume (vice versa).We summarise these distances by
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where p and g correspond to points on the surface of the predicted and actual tumour, respectively;M andN are
the number of points on the surface of the predicted and actual tumour, respectively;T andP the surface of the
actual tumour and predicted volumes.MeanDTA represents the degree ofmismatch between the two volumes,
with a high value indicating the existence of regions of dissimilarity between the two sets, and a zero indicates
that the volumes are identical. Unlike, theHausdorff distance whichmeasures the largest distance between two
segmentations to characterise theworstmatching region, and theDice coefficient is dependent on volume. The
meanDTA is themost appropriatemetric as itmeasures the overall surface distance between the segmented
predicted and actual tumour volume.
ThemeanDTAwas calculated usingWorld-match v9.0. Themodel evaluationwas performed in python
version 3.7, using sklearn and skimage packages respectively.
2.7. Tumour response classification
The actual and predicted percentage volume change at weeks 3 and 4were computed for each patient for all
models. A threshold of 30%was used to classify patients whowill benefit from treatment adaptation in either
week. The 30% reductionwas derived from a clinical study that suggested that tumourswith greater than 30% in
tumour reduction are good candidates for ART (Woodford et al 2007). Receiver-operating characteristic
analysis was performed to evaluate the overall performance of eachmodel.We report the sensitivity (true
positive rate), specificity (true negative rate), precision (ratio of correctly predicted positive cases over the total
number of predicted positive cases), accuracy (ratio of correctly predicted cases to the total number of cases) and
F1-measure (harmonic average of precision and sensitivity) inweeks 3 and 4 for eachmodel. The formal
definitions are provided in the supplementarymaterial. The sensitivity is defined as the percentage of patients
with a reduction ofmore than 30% thatwere correctly predicted to benefit fromARTby themethods. The
specificity represents the percentage of patients that were correctly predicted by themethods not benefit from
ART. Additional experiments, using the threshold of 20%and 40% to patients whowill benefit fromART are
provided in the supplementarymaterials.
2.8. Rigid image registration uncertainties
Whenperforming image registration, uncertainties are inevitable. These uncertainties can lead to errors in
model predictions, depending on the nature of registration failure. The impact of rigid registration uncertainties
was estimated by shifting eachCBCTwith a randomoffset sampled from a 3DGaussian distribution (μ= 0,
σ= 3mm). These parameters correspond to typically baseline shifts in lung cancer patients (Kanakavelu and
Samuel 2016).
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After these shifts, we calculated the volume,meanDTA, RMSE and SSIM. Simulationswere repeated 100
times. Simulated results were compared to the initial prediction results using the original registration.
Simulationswere only performed for the predictions inweek 3. This part of theworkwas carried out in python
version 3.7, using the SimpleITKpackage.
3. Results
3.1. Image registration
Thirty-nine patients were excluded; threewere because of unrelated pulmonary change (atelectasis), one
because of inadequate image quality (structures not visible) and 25 patients were excluded because they did not
have all the requiredCBCT images. Registration accuracywas visually assessed by examiningwhether the clip
boxeswere in the right positions andCBCTswell aligned to the pCT. Ten patients were excluded because of poor
rigid image registration failures.
3.2. Prediction of density changes in each voxel
An example of a prediction in one voxel using a linear, quadratic, cubic andGaussianmodel is shown infigure 1
of supplementarymaterial. It indicates that the linear andGaussianmodels performed better compared to the
quadratic and cubicmodels. Figure 2 shows a patient CBCT series visualised in the axial, sagittal and coronal
planes, predicted using the linearmodel.
It is evident that this patient displays visible tumour shrinkage on theCBCT acquired inweek 3 of RT; a
linearmodel predicts a visually similar image.Quantitatively, theGTVhas shrunk from12.85 cm3 (tumour
volumemeasured on pCT at the start of treatment) to 0.42 cm3 (tumour volume on theCBCT atweek 3). The
predicted tumour volume inweek 3 of RT for this patient was 0.32, 1.52, 0.91 and 2.71 cm3 for the linear,
Gaussian, quadratic and cubicmodels respectively.
Figure 2.A responder example patient: CBCT image at the start of RT, actual CBCT and predicted image inweek 3 of RT in axial,
sagittal and coronal views. The blue contour is theGTV from the planningCT.
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Figure 3 shows an example case of a patient whowith little tumour shrinkage. Both the predicted and actual
image of theCBCT acquired inweek 3 of RTdisplays little change. In this case, the tumour volume remains
nearly the same throughout treatment, with a 4% actual reduction in tumour size. The volume changewas
−7.66,−0.11,−34.11 and−78.89 cm3, indicating a 4%, 0.1%, 18%and 41%decrease in tumour volume from
the start of treatment as predicted by linear, Gaussian, quadratic and cubicmodels respectively.
3.3. Segmentation
After prediction, threshold-based segmentationwas applied to identify the tumour. On visual inspection, gross
segmentation errors were found in 3 cases and themajority of the patients (198 cases) had visually acceptable
segmentations. Figure 4 shows an example of a segmented tumour volume for a representative patient.
3.4.Model validation
For all patients, the average RMSE score for the linearmodel is provided infigure 5. The average RMSE for the
Gaussian, quadratic and cubicmodels is provided infigure 2 of supplementarymaterial. The high order
polynomial regressionmodels performedworst. The linearmodel performed acceptably andwas preferred.
Figure 3 of supplementarymaterial illustrates the performance of allmodels across all patients.
The SSIM for the linearmodel can be seen infigure 6. The SSIM for theGaussian, quadratic and cubic
models is shown infigure 4 of supplementarymaterial. The average SSIM score for linear, Gaussian, quadratic
and cubicmodels is 0.94, 0.94, 0.90 and 0.84 inweek 3 of RT, respectively. Inweek 4, the average SSIMof 0.93,
0.92, 0.92 and 0.86was observed for the linear, Gaussian, quadratic and cubicmodels respectively. These scores
indicatemostmodels predict tumours that look similar to the actual tumour, and the cubicmodel performed
worst.
Figure 3.Non-responder example patient: CBCT image at the start of RT, actual CBCT and predictedCBCT image inweek 3 of RT in
axial, sagittal and coronal views. The blue contour is theGTV at the start of treatment.
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Figure 7 shows the correlation between the predicted tumour volume change for the linearmodel and the
measured tumour volume change on theCBCT image acquired inweek 3 of RT. The scatter plots for the
Gaussian, quadratic and cubicmodels can be found infigure 5 of supplementarymaterial. The best correlation
between the predicted tumour volume change and themeasured tumour volume change is obtained using a
linearfit. The linearmodel predicted an average tumour volume of 52 cubic centimetres (cm3) at week 3
compared to themeasured tumour volume of 49 cubic cm3, an average range of 2 cm3. The ranges were
33.76 cm3, 58.88 cm3, 92.67 cm3 and 171.50 cm3 for the linear, Gaussian, quadratic and cubicmodels
respectively. Scatterplots depicting the correlation between the predicted andmeasured tumour volume change
inweek 4 of RT for allmodels can be found infigure 6 of supplementarymaterial. The Bland andAltman plots
Figure 4. Segmentation example-images and segmented tumour volume visualised on axial, sagittal and coronal axes. In blue is the
contour used to guide the tumour volume segmentation.
Figure 5.The average prediction error in pixel value, rootmean square error (RMSE) for the linearmodel for all patients; in (a)week 3,
and (b)week 4 respectively.
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Figure 6. Structural similarity indexmatrix (SSIM) for all patients for the linearmodel. (a) SSIM inweek 3 and (b)week 4. This implies
that the tumour shape predicted by allmodels is similar to the actual tumour shape at the treatment for themajority of the patients.
Figure 7.Correlation between the actual and predicted tumour volume change as a percentage (%) for the linearmodel inweek 3. The
black vertical and horizontal lines represent the threshold used to distinguish patients whomay or not benefit fromRT adaptation.
The red band is the confidence band for the regression line, showing the upper and lower confidence bounds for all points within the
range of the data.
8
Phys.Med. Biol. 66 (2021) 225002 LMAmugongo et al
showing the percentage difference between the actual and predicted tumour volume in bothweeks 3 and 4 are
provided infigures 7 and 8 of the supplementarymaterial.
3.5. Tumour response classification
Inweek 3, the sensitivity (true positive rate) for the linearmodel was 84%.Whereas, the specificity (true negative
rate)was 99% for the linearmodel, see table 1. The sensitivity and specificity of theGaussian, quadratic and
cubicmodels are shown in table 2 of supplementarymaterial. Overall, the linearfit performed best at identifying
patients whowill benefit from treatment adaption inweek 3, while the quadraticmodel performed acceptably
and the cubicmodel performedworst.
TP true positive, FP false positive, TN true negative, FN false negative, TPR true positive rate, andTNR true
negative rate.
Table 1 present the sensitivity, specificity, accuracy, precision and F-measure for the linearmodel inweek 4
of RT. The sensitivity for theGaussian, quadratic and cubicmodels is provided in table 3 of supplementary
material. Again, higher accuracywas observed using the linearfit compared to the othermodels.
Compared toweek 3, a lower sensitivity was observed in the gaussianmodel. This is a result of
overestimation by theGaussianmodel in week 4. Inweek 4 of RT, the false positive rate of 38% and 78%was
observed for the quadratic and cubicmodels, respectively. The linearfit identified 21%and 23%of the patients
to benefit fromRT adaptation inweeks 3 and 4, respectively. Additional experiments, using the threshold of 20%
and 40% to identify good responders for ART are provided in the supplementarymaterials, see figure 9. As
expected, with a higher threshold, the number of patients eligible for ARTdecreases. The sensitivity analysis
results are provided in tables 4 and 5 of supplementarymaterial. As seen the higher-order polynomialmodels
performedworse compared to the linearmodel.
3.6. Rigid image registration uncertainties
Table 2 shows themeanDTA, Standard deviation andmaxDTAbetween predicted and observed tumour
segmentation for all patients; for initial prediction and after applying randomXYZ shifts (100 simulations) using
the linearmodel. The registration uncertainties for theGaussian, quadratic and cubicmodels is illustrated in
table 6 of the supplementarymaterial. The results show that the predicted tumour volumewaswithin 1mm in
themajority of the patients. Plausible registration inaccuracies have only a very small impact on the results. The
registration uncertainties for theGaussian, quadratic and cubicmodels is illustrated in table 6 of the
supplementarymaterial.
DTAdistance to agreement, GP gaussian process,mmmillimetres, SD standard deviation.
ThemeanDTA for all simulations for two example patients are shown infigure 8; (a) a patientmost affected
by registration uncertainties and (b) the patient with themaximumDTA. The variations inmeanDTA for each
patient are also visible on the overlapped segmentation on the left. ThemeanDTA for all patients is shown in
figure 10 of supplementarymaterial. The standard deviation of themeanDTA for all patients is shown infigure
11 of the supplementarymaterial. Themean and standard deviation of the RMSE and SSIM for all simulations is
summarised in table 7 of supplementarymaterial.
Table 1.The performance of the linearmodel at weeks 3 and 4. The threshold value for volume change and tumour
response classification usedwas 0.3 (30%). The linear andGaussianmodels perform better at identifying true
positives and true negatives at week 3 thanweek 4.
TP FP TN FN TPR TNR Precision Accuracy F-measure
Week 3 43 2 148 8 0.84 0.99 0.96 0.95 0.9
Week 4 46 9 135 11 0.81 0.94 0.84 0.9 0.82
Table 2.Mean, SD andmaximumdistance to agreement between the actual and predicted tumour volume for the initial prediction and after
applyingXYZoffset.
Initial prediction Prediction after applying randomXYZ shifts, 100 simulations
Linear Linear
MeanDTA (mm) 0.55 0.60
SD (mm) 0.46 0.49
MaxDTA (mm) 3.42 3.61
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4.Discussion
To the best of our knowledge, this is thefirst study that has quantitatively predictedNSCLC tumour volume and
shape at later weeks during RTusing longitudinal CBCT images acquired up tomid-treatment of RT to
proactively informART early. Our results show that individualised regressionmodels built per-voxel using the
intensity values fromon-treatment CBCTs in the first twoweeks of RT can predict tumour shape and volume in
weeks 3 and 4 of RT, i.e. one and twoweeks ahead.
Several studies have retrospectively investigated the need for ART in lung cancer patients due to tumour
volume changes (Siker et al 2006, Britton et al 2007,Woodford et al 2007, Fox et al 2009) or intrathoracic changes
(Kwint et al 2014,Møller et al 2016). In a cohort of 13 patients, Guckenberger et al (2011) illustrated that
performingART twice (week 3 or 5) during RTdoes not underdose themicroscopic spread of the disease and
can reduce the dose to the lung by 5%–8%.Another study byGuckenberger, Kavanagh and Partridge (2012)
concluded that ART is safe and can improve tumour control probability. However, for ART to be effective
sufficient regression has to be observed early on during treatment (Sonke andBelderbos 2010).Most of the
studies in the literature, reported atelectasismaking up a large percentage of all adaptations, 10% in Persoon et al
(2015) and 12% inMøller et al (2014). In this study, patients with atelectasis were excluded, sincewe focused on
tumour regression.Woodford et al (2007) found that 40%of patients in their cohort had a sufficientmagnitude
of tumour reduction to benefit fromART.Monitoring anatomical changes on daily CBCTs,Møller et al (2016)
reported a false positive rate of 20% in patients requiring adaptation. In our study, the linearmodel achieved a
false positive rate of 16% and 19%atweeks 3 and 4 respectively. However, inspecting figure 7(a) shows that only
two patients werewrongly predicted to benefit fromARTusing the linearmodel.
Different studies have suggested the benefits of ARTbased on simulations. However, only a few studies have
shown the clinical outcome of ART implementation. Tvilum et al (2015)demonstrated that ART can improve
loco-regional control in a small cohort of 52 patients. Thefirst study to report the clinical outcome of ART, the
LARTIA trial reportedmarginal relapse in 6%of the patients and low toxicity (2%and 4%acute and lung
damage) (Ramella et al 2017). However, in both cases the decisions to adapt are qualitative, for example,
anatomical changes judged by radiation oncologists. Kwint et al (2014)proposed a semi-quantitative approach
to evaluate intrathoracic changes. However, they did not include tumour volume changes in their criteria.
Accounting for tumour position, lymphnodes, organs at risk and dosimetric impact,Møller et al (2016)
described stricter adaptation criteria.
In themajority of studies that have implemented ART strategies, adaptation is triggered by the changes
deemed detrimental as visually observed during RT. The unpredictable nature of triggered adaptation can
constraint resource allocation because arrangements for re-scanning or re-planning is onlymade once the
changes are detected (Sonke et al 2019). In busy departments, scheduling a re-scan and treatment re-planmay
take several days (up to 5 days). Our findings demonstrate thatwe can predict tumour changes early during RT,
suggesting that it is possible to identify patients whomay benefit fromART early on. Early identification of
Figure 8.Histograms of the simulatedmeanDTA for two example patients predicted using a linearmodel; (a) patient with themost
variation inDTA. (b)Patient withmaximumDTA.On the right of each histogram is the respective overlapped segmented volumes for
all simulations viewed on the axial axis.
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patients that benefit fromARTwill enable departments to allocate the required resources ahead of time.Our
approach is not intended to replace radiation oncologists but to improve the ART clinical workflowby removing
themanual inspection step in the selection of patients eligible for ART. Themanual step is error-prone and
subjective.
In our study, the linearmodel correctly predicted that 21% and 23%of patientsmay benefit fromART in
weeks 3 and 4, respectively. Accepting the false positive ratewould lead to 2 and 9 patients being re-planned
unnecessarily at weeks (3 and 4), since their tumour shrinkagewaswrongly predicted to be over 30%,while in
reality, it ranged from10.8 to 14.4% and 9.6%–29.1%, respectively. One patient had actual tumour regression of
29.1% and the linearmodel predicted a 34.4% reduction. Though the actual regression is notmore than 30%,
themodel predictionwas close. The 30% threshold used in this study is not intended to be a concrete principle
but is useful as a criterion to identify or ‘flag’ patients for adaptive planning evaluation.
Although the results of this study are promising, limitations exist. First, the quality of CBCT images is poor
compared to conventional CT. Intensity correctionwas applied according to themethod described by van
Timmeren et al (2017) to correct the distribution of intensities betweenCBCT images. However, image noise
and artefacts remain a challenge; standard 3DCBCT images acquired in free-breathingwere used in this study.
Possible solutions to this have been proposed in the literature by optimising scatter correction (Poludniowski
et al 2009) or performingmotion compensation (Rit et al 2009).
Second, prediction accuracy could have been affected by the biases in themodel, such as overfitting. To
overcome this challenge, four regressionmodels applying a linear, Gaussian, quadratic and cubicfit were used
and their prediction results were compared. Large errors were observed in the higher-order (quadratic and
cubic)models, and this can be a result of ill-conditioning, which causes the coefficients to be sensitive to small
variations in the data. Lung cancer patients are now imaged daily.More information provided by daily CBCTs
can potentially improve prediction accuracy, especially for the higher-order regressionmodels.
In this study, a threshold value of 374HUwas used.However, the sensitivity analysis applying two different
threshold values showed that the segmentation did not deteriorate the results, see tables 4 and 5 of
supplementarymaterial. The linearmodel still performed better at identifying patients with large tumour
regression to benefit fromART.Different institutions should explore and determine the appropriate threshold
values or perhaps apply an individual threshold value for each patient. Another limitation is that threshold
selection andfinal evaluation of themodel was performed on the same dataset. In addition, our segmentation
approach uses an expanded region to guide the thresholding process. Though this is sensible for tumours
surrounded by lung tissue, this can lead to tumour volume overestimation for tumours adjacent to the chest wall
ormediastinal because normal surrounding tissuewith similar densitymay be included in tumour volume.
Consequently, underestimating relative volume reduction for these tumours. To reduce the impact of
overestimation of tumour volume, the lung contour was then used to ensure the expanded region did not extend
into other tissue outside the lung, i.e.mediastinum, diaphragmor chest wall. Also, the automatic segmentation
used in this study is limited by qualitative assessment based on visual inspection only. Thus, further
improvement in tumour volume segmentationmay improve predictions.
Another issue that could have affected our results is image registration. In this study rigid image registration
was used, rigid image registration cannot deal with complex deformations, for example, large anatomical
changes, includingweight loss and normal tissue response. To estimate the impact of image registration
uncertainties, we simulated the prediction 100 times, applying a random3D translation.We found that the
averagemeanDTAwas off by less than 3mm in all patients for all fourmodels implying that image registration
uncertainties did not affect the results in themajority of the patients. Lastly, the lack of an external validation
dataset can limit the clinical relevance of this study.
Becausewe are not extracting features of the segmented tumour on subsequent CBCT images, our approach
maintains the spatial and temporal information of the tumour. The spatial information is important because
tumours do not change homogeneously, different regions of the tumour are expected to respond differently to a
treatment. Also, our approach applies fits in each voxel individually, thus can be applied to any patient.
Clinically, ourmodel will be useful in identifying tumours that are likely to change during treatment early. As
part of a clinical workflow, aCT scan can be scheduled proactively for patients identified as good responders.
Early identification of patients with large tumour regressionwill give radiation oncologists sufficient time to
determine the safety of ART for each patient. However, to evaluate the safety of treatment adaptation,more
information about changes around the surrounding tissues will be needed to distinguish themode of tumour
change, i.e. elastic and inelastic change. The former is favourable for the adaptation of treatment volumes,
whereas the latter implies that treatment volumes should remain unchanged, at least for an intermediate dose
level. A boost on the shrunken tumourmay bemore appropriate. Futureworkwill explore complementary
techniques such as deformable image registration to investigate changes happening to the surrounding tissue,
therefore distinguishmodes of tumour change. In addition, futureworkwill also explore associating early
regressionwith clinical data and explore the possibility to predict tumour control and patient’s outcome early.
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Wehave shown that individualised regressionmodels built per voxel on intensity values fromon-treatment
CBCT images can predict tumour volume and shape inweeks 3 and 4 of RT. If we can identify tumours
responding to treatment early, patients that will benefit fromplan adaption can be identified early.
5. Conclusion and futureworks
In this study, we have shown that it is possible to predict the tumour volume and shape inweeks 3 and 4 of RT,
using intensity values extracted per-voxel longitudinally across CBCT images acquired in the first half of RT
treatment. Image registration uncertainties did not impact the prediction accuracy. Finally, the linearmodel
achieved good results at predicting the tumour volume and identifying patients whowill or not benefit fromRT
adaptation early on during the course of RT.
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